ATE15973T1 - Verfahren zur fraktionierung von blutplasma. - Google Patents

Verfahren zur fraktionierung von blutplasma.

Info

Publication number
ATE15973T1
ATE15973T1 AT81101288T AT81101288T ATE15973T1 AT E15973 T1 ATE15973 T1 AT E15973T1 AT 81101288 T AT81101288 T AT 81101288T AT 81101288 T AT81101288 T AT 81101288T AT E15973 T1 ATE15973 T1 AT E15973T1
Authority
AT
Austria
Prior art keywords
blood plasma
fractionation
procedure
fibronectin
isolating
Prior art date
Application number
AT81101288T
Other languages
English (en)
Inventor
Donald G Wallace
Phillip M Schneider
John L Lundblad
Original Assignee
Miles Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Lab filed Critical Miles Lab
Application granted granted Critical
Publication of ATE15973T1 publication Critical patent/ATE15973T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT81101288T 1980-03-05 1981-02-23 Verfahren zur fraktionierung von blutplasma. ATE15973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/127,340 US4341764A (en) 1980-03-05 1980-03-05 Method of preparing fibronectin and antihemophilic factor
EP81101288A EP0035202B1 (de) 1980-03-05 1981-02-23 Verfahren zur Fraktionierung von Blutplasma

Publications (1)

Publication Number Publication Date
ATE15973T1 true ATE15973T1 (de) 1985-10-15

Family

ID=22429606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81101288T ATE15973T1 (de) 1980-03-05 1981-02-23 Verfahren zur fraktionierung von blutplasma.

Country Status (9)

Country Link
US (1) US4341764A (de)
EP (1) EP0035202B1 (de)
JP (1) JPS56139418A (de)
AT (1) ATE15973T1 (de)
CA (1) CA1164342A (de)
DE (1) DE3172567D1 (de)
DK (1) DK156697C (de)
ES (1) ES500122A0 (de)
MX (1) MX7113E (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS584074U (ja) * 1981-06-30 1983-01-11 井上　岱介 風車ネオン式検電器
EP0076870B1 (de) * 1981-10-12 1985-06-05 Armour Pharmaceutical Company Verfahren zur Herstellung von hochgereinigtem Antihaemophiliefaktor
US4391749A (en) * 1981-10-19 1983-07-05 La Jolla Cancer Research Foundation Method for the purification of collagens
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS59134732A (ja) * 1983-01-21 1984-08-02 Green Cross Corp:The フイブロネクチン・生理活性物質複合体の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
JPS6133124A (ja) * 1983-11-04 1986-02-17 ラルフ　シルヴア−マン 異性々疾患を治療するための培養間葉細胞から抽出した巨大分子
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
AT385658B (de) * 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4587122A (en) * 1985-04-23 1986-05-06 The Green Cross Corporation Fibronectin-dextran-drug complex and method of preparation thereof
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
DK475386D0 (da) 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5453489A (en) * 1992-01-31 1995-09-26 La Jolla Cancer Research Foundation Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
US5629291A (en) * 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US5821220A (en) * 1995-06-07 1998-10-13 Andre Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
NZ505424A (en) 1998-01-23 2002-09-27 Csl Ltd Purification of fibrinogen
PT2193809E (pt) 1999-02-22 2015-08-24 Baxter Int Formulações de fator viii livres de albumina
DE60042343D1 (de) * 1999-12-23 2009-07-16 Csl Ltd Abtrennung von fibrinogen von plasmaproteasen
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
BRPI0921429B1 (pt) * 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
ME02622B (de) 2009-05-25 2017-06-20 H Lundbeck As Herstellung von nalmefen-hydrochlorid aus naltrexon
IL213864A0 (en) 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
US8844879B2 (en) * 2011-12-12 2014-09-30 The Boeing Company Wing variable camber trailing edge tip
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma

Also Published As

Publication number Publication date
ES8202029A1 (es) 1982-01-01
DE3172567D1 (en) 1985-11-14
EP0035202A3 (en) 1982-09-01
DK98581A (da) 1981-09-06
JPS56139418A (en) 1981-10-30
CA1164342A (en) 1984-03-27
DK156697B (da) 1989-09-25
EP0035202A2 (de) 1981-09-09
DK156697C (da) 1990-02-05
US4341764A (en) 1982-07-27
EP0035202B1 (de) 1985-10-09
ES500122A0 (es) 1982-01-01
MX7113E (es) 1987-06-29

Similar Documents

Publication Publication Date Title
ATE15973T1 (de) Verfahren zur fraktionierung von blutplasma.
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
ATE32304T1 (de) Verfahren zur zerlegung von blutplasma.
ATA939375A (de) Verfahren zur fraktionierung von blutplasma
DE3583796D1 (de) Verfahren zur behandlung von materialien mittels organosiloxanverbindungen.
ATE17363T1 (de) Verfahren zur herstellung von hochelastischen schaeumen und alkoxysilicium-verbindung(en) als schaumstabilisatoren hierfuer.
AT378945B (de) Verfahren zur behandlung von soleabschlaemmungen
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
PT72724B (de) Verfahren zur herstellung von pyrimidyl-chinazolinen
PT76969B (de) Verfahren zur chargenweisen herstellung von essig
DE69016249D1 (de) Verfahren zur elektrochemischen Behandlung von Schwefelwasserstoff enthaltendem Gas.
AT373914B (de) Verfahren zur stereospezifischen herstellung von d-carbamylderivaten von alpha-hydroxysaeuren
DE58907981D1 (de) Verfahren zur Entschwefelung von Koksofengas.
AT378198B (de) Verfahren zur hydrobehandlung von kohlenstoffhaltigem material
DE3480702D1 (de) Verfahren zur metathese von alkenylestern.
DD156081A1 (de) Verfahren zur oxydation von alpha-alkylierten,benzyl-substituierten 2-thiopyriden-1-oxiden
ATE50553T1 (de) Verfahren zur trennung von racematen.
ATE9063T1 (de) Prothrombin enthaltende therapeutische zusammensetzungen und verfahren zur herstellung enzymatisch aktiver blutgerinnungsfaktoren aus prothrombin enthaltenden blutfraktionen.
AT360161B (de) Verfahren zur herstellung von enteral hoch- resorbierbaren zubereitungen von an sich schwer resorbierbaren arzneistoffen
AT376363B (de) Verfahren zur extraktion von coffein
DE3021991A1 (de) Verfahren zur herstellung von schuhwerk und nach diesem verfahren ausgebildetes schuhwerk
AT364373B (de) Verfahren zur aufarbeitung des bei der herstellung von cyanurchlorid anfallenden restgases
DE2833826A1 (de) Verfahren zur trennung und spaeteren reinigung von halbleitersubstraten
PT72113B (de) Verfahren zur herstellung von kamstreifen
ATE22566T1 (de) Verfahren zur herstellung von blutprodukten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee